Pharmaventures

Pharmaventures company information, Employees & Contact Information

Explore related pages

Related company profiles:

PharmaVentures is a premier transaction advisory firm and a leading international company in M&A and licensing deals, valuations, market access and strategic advice. For over 30 years, PharmaVentures has acted as advisor on over 1,000 deal related assignments covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide. PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of strategic planning, deal making and commercial due diligence. PharmaVentures is well known for its deep insight into deal structures and its success for generating interest from both buyers and sellers leading to positive outcomes for its clients. PharmaVentures’ services include: • M&A (divestments, mergers, acquisitions, and strategic transactions) • Licensing (in and out licensing) • Fundraising Support • Strategy (commercialisation, deal strategy, due diligence, market entry) • Valuations (licensing, M&A, and fundraising) • Pricing and Market Access PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356). For more details, visit https://www.pharmaventures.com

Company Details

Employees
31
Founded
-
Address
One Kingdom Street, Fourth Floor,paddington,united Kingdom
Phone
44 1865 332 700
Email
en****@****res.com
Industry
Business Consulting And Services
NAICS
Management, Scientific, and Technical Consulting Services
Management Consulting Services
Other Scientific and Technical Consulting Services
Other Management Consulting Services
HQ
London
Looking for a particular Pharmaventures employee's phone or email?

Pharmaventures Questions

News

PharmaVentures acts as exclusive M&A advisor to the PE firm capiton AG on the successful sale of MiP Pharma's Sterile Production Facility to FAMAR Group - PR Newswire

PharmaVentures acts as exclusive M&A advisor to the PE firm capiton AG on the successful sale of MiP Pharma's Sterile Production Facility to FAMAR Group PR Newswire

PharmaVentures Appoints Samara Ferguson as Vice President to Lead Pricing and Market Access Team - PR Newswire

PharmaVentures Appoints Samara Ferguson as Vice President to Lead Pricing and Market Access Team PR Newswire

Sekhmet Pharmaventures appoints Mukesh Agarwal as Chief Financial Officer - Express Pharma

Sekhmet Pharmaventures appoints Mukesh Agarwal as Chief Financial Officer Express Pharma

Sekhmet Pharmaventures appoints Santosh Mahil as MD & CEO - People Matters India

Sekhmet Pharmaventures appoints Santosh Mahil as MD & CEO People Matters India

PAG-led Sekhmet Pharmaventures appoints Santosh Mahil as MD and CEO - IndiaMedToday

PAG-led Sekhmet Pharmaventures appoints Santosh Mahil as MD and CEO IndiaMedToday

Sekhmet Pharmaventures welcomes Nivedita Agrawal as senior director-HR - HR Katha

Sekhmet Pharmaventures welcomes Nivedita Agrawal as senior director-HR HR Katha

Santosh Mahil appointed CEO of Sekhmet Pharmaventures - Express Pharma

Santosh Mahil appointed CEO of Sekhmet Pharmaventures Express Pharma

Sekhmet Pharmaventures appoints Nivedita Agrawal as Senior Director HR - People Matters India

Sekhmet Pharmaventures appoints Nivedita Agrawal as Senior Director HR People Matters India

CCI Gives Nod To Deal Involving Sekhmet Pharmaventures, Optimus Drugs - BW Healthcare World

CCI Gives Nod To Deal Involving Sekhmet Pharmaventures, Optimus Drugs BW Healthcare World

Sekhmet Pharmaventures appoints Nivedita Agrawal as Senior Director - HR - ETHRWorld.com

Sekhmet Pharmaventures appoints Nivedita Agrawal as Senior Director - HR ETHRWorld.com

UK-based PharmaVentures enhances access for South Korean biotechs - BioSpectrum Asia

UK-based PharmaVentures enhances access for South Korean biotechs BioSpectrum Asia

PAG-led Sekhmet Pharmaventures ropes in Anil Khubchandani as MD and CEO - BioSpectrum India

PAG-led Sekhmet Pharmaventures ropes in Anil Khubchandani as MD and CEO BioSpectrum India

PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEO - The Economic Times

PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEO The Economic Times

Glenmark might be selling its API business. Why? - Forbes India

Glenmark might be selling its API business. Why? Forbes India

PE-owned Sekhmet Pharma gets former Lupin, Shilpa Medicare exec as new CEO - VCCircle

PE-owned Sekhmet Pharma gets former Lupin, Shilpa Medicare exec as new CEO VCCircle

Nirma, Sekhmet Pharmaventures vie for $731 mn Glenmark Life stake: Reports - Business Standard

Nirma, Sekhmet Pharmaventures vie for $731 mn Glenmark Life stake: Reports Business Standard

Sekhmet Pharmaventures, Nirma in race to acquire Glenmark's API business - Business Standard

Sekhmet Pharmaventures, Nirma in race to acquire Glenmark's API business Business Standard

Sekhmet Pharmaventures onboards Uma Rao Ganduri as CHRO - People Matters India

Sekhmet Pharmaventures onboards Uma Rao Ganduri as CHRO People Matters India

CCI clears deal involving Sekhmet Pharmaventures and Optimus Drugs - Express Pharma

CCI clears deal involving Sekhmet Pharmaventures and Optimus Drugs Express Pharma

Sekhmet Pharmaventures Onbaords Anil Khubchandani As The New MD And CEO - BW People

Sekhmet Pharmaventures Onbaords Anil Khubchandani As The New MD And CEO BW People

PAG-led consortium appoints Santosh Mahil as MD & CEO of Sekhmet Pharmaventures - BusinessLine

PAG-led consortium appoints Santosh Mahil as MD & CEO of Sekhmet Pharmaventures BusinessLine

Sekhmet Pharmaventures appoints Khubchandani as MD - BusinessLine

Sekhmet Pharmaventures appoints Khubchandani as MD BusinessLine

Anil Khubchandani appointed as MD, CEO of Sekhmet Pharmaventures - The Hindu

Anil Khubchandani appointed as MD, CEO of Sekhmet Pharmaventures The Hindu

Valuation benefits of structure-enabled drug discovery - Nature

Valuation benefits of structure-enabled drug discovery Nature

Uma Rao Ganduri Joins Sekhmet Pharmaventures As CHRO - BW People

Uma Rao Ganduri Joins Sekhmet Pharmaventures As CHRO BW People

Unichem Labs gets Rs 270 cr as first tranche of payment for Optimus stake sale - CNBC TV18

Unichem Labs gets Rs 270 cr as first tranche of payment for Optimus stake sale CNBC TV18

Top Pharmaventures Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant